Navigation Links
MedImmune's Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
Date:6/6/2008

GAITHERSBURG, Md., June 6 /PRNewswire/ -- MedImmune, the global biologics unit of AstraZeneca, announced today that the Montgomery County Chamber of Commerce has presented Brian Rosen, senior director, government affairs, with its 2008 Chairman's Award at the organization's 49th Annual Dinner held recently at the Bethesda North Marriott Hotel and Conference Center.

"The Montgomery County Chamber of Commerce plays a vital role in representing the local business community at the regional and state levels, which is why MedImmune is proud to be an active corporate member," said Lori Weiman, vice president of public affairs. "We are pleased that the chamber has chosen to recognize Brian's commitment to its organization with the chairman's award."

The Montgomery County Chamber of Commerce Annual Chairman's Award recognizes an individual for outstanding service and contributions to the business community. Mr. Rosen has represented MedImmune as a board member of the Montgomery County Chamber for the past five years. He is currently the co-chair for the legislative affairs committee and a member of the executive committee and the board of directors.

About MedImmune

MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN) and is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland. MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience. For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Brian J.G. Pereira, M.D. Joins Biodels Board of Directors
2. MiMedx Announces Brian J. Splan as President
3. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
4. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
5. Nanotube production leaps from sooty mess in test tube to ready formed chemical microsensors
6. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
7. Aflac Honored with Corporate Citizenship Award
8. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
9. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
10. Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
11. PNAS paper and its authors honored for scientific excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... SANTA CLARA, Calif. , Sept. 22, 2014 ... ), the leading source of health information, today released ... that provide novel insights regarding physician and patient perspectives ...  Dr. Eric Topol , a leading authority in ... as both Editor-in-Chief of Medscape and Chief Academic Officer ...
(Date:9/22/2014)... Scientists at The University of Manchester have generated a new ... most complex of its kind ever created. , ... trying to create one for over a quarter of a ... Nature Chemistry . , Consisting of two molecular ... the structure,s interlocked molecules are tiny each triangle is ...
(Date:9/22/2014)... Sept. 22, 2014 US demand to rise ... specialty biocides is forecast to rise 3.9 percent per ... demand is projected to increase 1.3 percent per year ... strong rebound in construction expenditures will support demand for ... markets, while growth in consumer spending and manufacturing output ...
(Date:9/22/2014)... 2014 Invisible Sentinel Inc., a ... food and beverage industries, announced today that its ... a non-exclusive agreement by Enartis, a global provider ... an Esseco Group company headquartered in Trecate, Italy, ... and other global markets for their own in-winery ...
Breaking Biology Technology:WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 2WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 3WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 4US Biocides Market 2US Biocides Market 3Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 2Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 3
... 2011 Double Eagle Holdings, Ltd. (OTCQB: DROP), the parent ... week a partnership with golf superstar Tiger Woods that will ... Woods and CEO of FUSE Science Adam Adler are set ... CNBC today Monday, November 21, at 12:30 p.m. during an ...
... 21, 2011 Phase I Single Dose ... and Tolerability Convergence Pharmaceuticals Limited ("Convergence"), the ... value analgesic medicines, today announces that the multiple ascending ... class calcium channel blocker CNV2197944, for the treatment of ...
... of revenues from MD Consult, First Consult subscriptions sold ... in Ethiopia Elsevier , a world-leading ... services, announced today that it will contribute to ... of Hope" campaign, providing medical assistance and support ...
Cached Biology Technology:Tiger Woods Gives Exclusive First Interview Since POWERED by FUSE Announcement! 2Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944 2Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944 3Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944 4Elsevier Supports International Crisis Aid Through 'Pillars of Hope' Campaign 2Elsevier Supports International Crisis Aid Through 'Pillars of Hope' Campaign 3
(Date:9/21/2014)... of children with autism are significantly less likely to ... than the mothers of children who are developing normally, ... Institute has found. , Low iron intake was associated ... child if the mother was 35 or older at ... suffered from metabolic conditions such as obesity hypertension or ...
(Date:9/21/2014)... -- In recent years, new strains of bacteria have ... year, these superbugs, including drug-resistant forms of tuberculosis and ... kill at least 23,000. Despite the urgent need for ... of antibiotics in the past decade. , MIT engineers ... superbugs. Using a gene-editing system that can disable any ...
(Date:9/19/2014)... dinosaurs a newly discovered hadrosaur with a ... Rhinorex condrupus by paleontologists from North ... in what is now Utah approximately 75 million ... Rhinorex, which translates roughly into "King Nose," was ... Cretaceous hadrosaurs like Parasaurolophus and Edmontosaurus. Hadrosaurs are ...
Breaking Biology News(10 mins):Mothers of children with autism less likely to have taken iron supplements 2Battling superbugs 2Battling superbugs 3Battling superbugs 4New hadrosaur noses into spotlight 2
... by Barry Smart published this month by SAGE challenges ... increasing consumerism. The book argues that continuing pursuit ... is socially undesirable and ecologically unsustainable. It provides a ... and its social, economic, and environmental consequences by drawing ...
... HEIDELBERG, Germany, 12 April 2010 More than 120 leading ... EMBO Meeting 2010 the second annual life sciences conference ... held in Barcelona from 4 - 7 September 2010. ... Elizabeth Blackburn Roles of telomeres & telemorase in health ...
... be applied under the Integral Coastal Zone Management (ICZM) for the ... EC Framework Progamme 7 and directed by Universitat Autnoma de Barcelona, ... four years. Researchers will be analysing 11 ... of the Adriatic Sea, and the islands of the Aegean Sea. ...
Cached Biology News:'Consumer Society' by Barry Smart 2Call for abstracts and registration the EMBO Meeting 2010 2Call for abstracts and registration the EMBO Meeting 2010 3Birth of a scientific project to save the Mediterranean coast 2Birth of a scientific project to save the Mediterranean coast 3Birth of a scientific project to save the Mediterranean coast 4